N-(Phenylacetyl)guanosine(CAS: 132628-16-1)

N-(Phenylacetyl)guanosine (CAS: 132628-16-1) must comply with GHS classification for hazardous substances, REACH regulations for the registration, evaluation, authorization, and restriction of chemicals in the EU, and FDA and EPA requirements for pharmaceuticals and environmental protection in the US. These guidelines ensure safe handling, storage, transportation, and disposal of the compound.

There are alternative reagents and synthetic pathways available for the synthesis of N-(Phenylacetyl)guanosine (CAS: 132628-16-1). Common alternatives include 5-Aza-2’-deoxyguanosine and other nucleoside analogs. These alternatives can provide similar functionalities while potentially offering different chemical or biological properties.

The market for N-(Phenylacetyl)guanosine (CAS: 132628-16-1) is showing a steady growth due to its potential applications in antiviral research and pharmaceuticals. Research trends indicate increasing interest in its use as a therapeutic agent and as a model compound for studying nucleoside metabolism. The compound is also being explored for its potential in cancer research and as a component in drug delivery systems.

Waste containing N-(Phenylacetyl)guanosine (CAS: 132628-16-1) should be collected in appropriate containers and labeled accordingly. It should be handled with care to prevent spillage and exposure. For disposal, consult local environmental protection regulations and consider professional waste disposal services. Incineration is one method, but ensure it is conducted in an environmentally safe manner to avoid pollution. Always follow safety protocols and ensure proper documentation of waste management practices.